Prolonged c-Jun expression in the basolateral amygdala following bulbectomy: Possible implications for antidepressant activity and time of onset

Molecular Brain Research

Volumn 76, Issue 1, 2000, Pages 7-17

  Wrynn, Aileen S ^a,b   Sebens, Jantiena B ^b   Koch, Tineke ^b   Leonard, Brian E ^a   Korf, Jakob ^b  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Amygdala; Degeneration; Immediate early gene Jun; Model of depression; Olfactory bulbectomy; Plasticity; Serotonergic reinnervation

Indexed keywords

ANTIDEPRESSANT AGENT; PROTEIN C JUN; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL MEMBRANE; DEGENERATION; DEPRESSION; GENE EXPRESSION; IMMUNOREACTIVITY; MALE; NONHUMAN; OLFACTORY BULBECTOMY; PLASTICITY; PRIORITY JOURNAL; RAT; REINNERVATION; SILVER STAINING;

AMYGDALA; ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; OLFACTORY BULB; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; SEROTONIN; SILVER STAINING; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 0034629519     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00326-5     Document Type: Article

References (81)

1. Aggleton J.P. The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci. 16:1993;328-333.
2. D.G. Amaral, J.L. Price, A. Pitkanen, S.T. Carmichael, Anatomical organisation of the primate amygdaloid complex, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 1-66.
3. Araki H., Kawashima K., Uchiyama Y., Aihara H. Involvement of amygdaloid catecholaminergic mechanism in suppressive effects of desipramine and imipramine on duration of immobility in rats forced to swim. Eur. J. Pharmacol. 113:1985;313-318.
4. Beck C.H. Acute treatment with antidepressant drugs selectively increases the expression of c-fos in the rat brain. J. Psychiatry Neurosci. 20:1995;25-32.
5. Beck C.H., Fibiger H.C. Chronic desipramine alters stress-induced behaviors and regional expression of the immediate early gene, c-fos. Pharmacol. Biochem. Behav. 51:1995;331-338.
6. Björklund A., Nobin A., Stenevi U. Regeneration of central serotonin neurons after axonal degeneration induced by 5,6-dihydroxytryptamine. Brain Res. 50:1973;214-220.
7. Brecht S., Gass P., Anton F., Bravo R., Zimmermann M., Herdegen T. Induction of Jun and suppression of CREB transcription factor proteins in axotomized neurons of substantia nigra covariation with tyrosine hydroxylase. Mol. Cell. Neurosci. 5:1994;431-441.
8. Brecht S., Martin-Villalba A., Zuschratter W., Bravo R., Herdegen T. Transection of rat fimbria-fornix induces lasting expression of Jun protein in axotomized septal neurons immunonegative for choline acetyltransferase and nitric oxide synthase. Exp. Neurol. 134:1995;112-125.
9. Broekkamp C.L., Garrigou D., Lloyd K.G. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats. Pharmacol. Biochem. Behav. 13:1980;429-434.
10. Brunjes P.C. Lessons from lesions: the effects of olfactory bulbectomy. Chem. Senses. 17:1992;729-763.
11. Butterworth N.J., Dragunow M. Medial septal neurons express Jun but do not undergo DNA fragmentation after fornix-fimbria transections. Mol. Brain Res. 43:1996;1-12.
12. Catarelli M., Demael A. Basal plasma corticosterone level after bilateral selective lesions of the olfactory pathways in the rat. Experientia. 42:1986;169-171.
13. Cairncross K.D., Cox B., Forster C., Wren A. The ability of local injections of 6-OHDA, 5,6-DHT and 5,7-DHT into the olfactory bulbs, to mimic the effects of bilateral bulbectomy in the rat. Br. J. Pharmacol. 61:1977;145P-146P.
14. Coffey C.E., Wilkinson W.E., Weiner R.D., Parashos I.A., Djang W.T., Webb M.C., Figiel G.S., Spritzer C.E. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch. Gen. Psychiatry. 50:1993;7-16.
15. Curran T., Franza B.R. Fos and Jun: the AP-1 connection. Cell. 55:1988;395-397.
16. Dolan R.J., Calloway S.P., Thacker P.F., Mann A.H. The cerebral cortical appearance in depressed subjects. Psychol. Med. 16:1986;775-779.
17. Dragunow M., deCastro D., Faull R.L.M. Induction of fos in glia-like cells after focal brain injury but not during Wallerian degeneration. Brain Res. 527:1990;41-54.
18. Dragunow M., Preston S. The role of inducible transcription factors in apoptotic nerve cell death. Brain Res. Rev. 21:1995;1-28.
19. Drevets W.C., Raichele M.E. Neuroanatomical circuits in depression: implications for treatment mechanisms. Psychopharmacol. Bull. 28:1992;261-274.
20. Drevets W.C., Videen T.O., Price J.L., Preskom S.H., Carmichael S.T., Raichle M.E. A functional anatomical study of unipolar depression. J. Neurosci. 12:1992;3628-3641.
21. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry. 54:1997;597-606.
22. Duncan G.E., Breese G.R., Criswell H., Stumpf W.E., Mueller R.A., Covey J.B. Effects of antidepressant drugs injected into the amygdala on behavioural responses of rats in the forced swim test. J. Pharmacol. Exp. Ther. 238:1986;758-762.
23. Duncan G.E., Knapp D.J., Johnson K.B., Breese G.R. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity. J. Pharmacol. Exp. Ther. 277:1996;1076-1089.
24. Ferrer I., Pozas E., Ballabriga J., Planas A.M. Strong Jun/AP-1 immunoreactivity is restricted to apoptotic cells following intracerebral ibotenic acid injection in developing rats. Neurosci. Res. 28:1997;21-31.
25. Garrigou D., Broekkamp C.L., Lloyd K.G. Involvement of the amygdala in the effects of antidepressants on the passive avoidance deficits in bulbectomised rats. Psychopharmacology. 74:1981;66-70.
26. Grecksch G., Zhou D., Franke C., Schröder U., Bernhard S., Becker A., Huether G. Influence of olfactory bulbectomy and subsequent imipramine treatment on 5-hydroxytryptaminergic presynapses in the rat frontal cortex: behavioural correlates. Br. J. Pharmacol. 122:1997;1725-1731.
27. Herdegen T., Blume A., Buschmann T., Georgakopoulos E., Winter C., Schmid W., Hsieh T.F., Zimmermann M., Gass P. Expression of activating transcription factor-2, serum response factor and cAMP/Ca response element binding protein in the adult rat brain following generalized seizures, nerve fibre lesion and ultraviolet irradiation. Neuroscience. 81:1997;199-212.
28. Herdegen T., Brecht S., Kummer W., Mayer B., Leah J., Bravo R., Zimmermann M. Persisting expression of JUN and KROX transcription factors and nitric oxide synthase in rat central neurons following axotomy. J. Neurosci. 13:1993;4130-4145.
29. Herdegen T., Skene P., Bähr M. The Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. T.I.N.S. 20:1997;227-231.
30. T. Herdegen, M. Zimmermann, Expression of Jun and Jun D transcription factors represent specific changes in neuronal gene expression following axotomy, in: F.J. Seil (Ed.), Progress in Brain Research, Elsevier, Amsterdam, 1994, pp. 153-171.
31. Honkaniemi J., Kainu T., Ceccatelli S., Rechardt L., Hökfelt T., Pelto-Huikko M. Fos and jun in rat central amygdaloid nucleus and paraventricular nucleus after stress. NeuroReport. 3:1992;849-852.
32. Horowski R., Sastre-Y-Hernandez M. Clinical effects of the neurotrophic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports. Curr. Ther. Res. 38:1985;23-29.
33. Hughes P.E., Alexi T., Hefti F., Knusel B. Axotomised septal cholinergic neurons rescued by nerve growth factor or neurotrophin-4/5 fail to express the inducible transcription factor Jun. Neuroscience. 78:1997;1037-1049.
34. R.L. Isaacson, The Limbic System, Plenum, New York, 1982.
35. Jesberger J.A., Richardson J.S. Animal models of depression: Parallels and correlates to severe depression in humans. Biol. Psychiatry. 20:1985;764-784.
36. Jesberger J.A., Richardson J.S. Brain output dysregulation induced by olfactory bulbectomy: an approximation in the rat of major depressive disorder in humans? Int. J. Neurosci. 38:1988;241-265.
37. Kelly J.P., Wrynn A.S., Leonard B.E. The olfactory bulbectomized rat as a model of depression: An update. Pharmacol. Ther. 75:1997;1-17.
38. Kiessling M., Gass P. Immediate early gene expression in experimental epilepsy. Brain Pathol. 3:1993;381-393.
39. Kiessling M., Gass P. Stimulus-transcription coupling in focal cerebral ischemia. Brain Pathol. 4:1994;77-83.
40. Kitayama I., Yaga T., Kayahara T., Nakano K., Murase S., Otani M., Nomura J. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol. Psychiatry. 42:1997;687-696.
41. Krishnan K.R., McDonald W.M., Escalona P.R., Doraiswamy P.M., Na C., Husain M.M., Figiel G.S., Boyko O.B., Ellinwood E.H., Nemeroff C.B. Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch. Gen. Psychiatry. 49:1992;553-557.
42. Kronfol Z., House J.D. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls. Acta Psychiatr. Scand. 80:1989;142-147.
43. Leah J.D., Herdegen T., Bravo R. Selective expression of Jun proteins following axotomy and axonal transport block in peripheral nerves in the rat: Evidence for a role in the regeneration process. Brain Res. 566:1991;198-207.
44. Leah J.D., Herdegen T., Murashov A., Dragunow M., Bravo R. Expression of immediate early gene proteins following axotomy and inhibition of axonal transport in the rat central nervous system. Neuroscience. 57:1993;53-66.
45. J.E. LeDoux, Emotion and the amygdala, in: J.P. Aggleton (Ed.), The Amygdala, Neurobiological Aspects of Emotion, Memory and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 339-354.
46. LeDoux J.E. Emotional memory systems in the brain. Behav. Brain Res. 58:1993;69-79.
47. Lino de Oliveira C., Guimares F.S., Del Bel E.A. Jun mRNA expression in the hippocampal formation induced by restraint stress. Brain Res. 753:1997;202-208.
48. Lumia A.R., Teicher M.H., Salchli F., Ayers E., Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587:1992;181-185.
49. Masquilier D., Sassone-Corsi P. Transcriptional cross-talk: Nuclear factors CREM and CREB bind to AP-1 sites and inhibit activation by Jun. J. Biol. Chem. 267:1992;22460-22466.
50. McAdams C., Leonard B.E. Neutrophil and monocyte phagocytosis in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;971-984.
51. Melia K.R., Ryabinin A.E., Schroeder R., Bloom F.E., Wilson M.C. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J. Neurosci. 10:1994;5929-5938.
52. Mizokawa T., Kimura K., Ikoma Y., Hara K., Oshino N., Yamamoto T., Ueki S. The effect of a selective phosphodiesterase inhibitor rolipram, on muricide in olfactory bulbectomized rats. Jpn. J. Pharmacol. 48:1988;357-364.
53. Morgan J.L., Curran T. Stimulus-transcription coupling in the nervous system: Involvement of the inducible proto-oncogenes fos and Jun. Annu. Rev. Neurosci. 14:1991;421-451.
54. Morinobu S., Duman R.S. Induction of BDNF mRNA by electroconvulsive seizure (ECS) and antidepressants in rat frontal cortex. Soc. Neurosci. Abstr. 19:1993;499.
55. Morinobu S., Nibuya M., Duman R.S. Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropharmacology. 3:1995;221-228.
56. Mulderry P.K., Dobsen S.P. Regulation of VIP and other neuropeptides by Jun in sensory neurons: implications for the neuropeptide response to axotomy. Eur. J. Neurosci. 8:1996;2479-2491.
57. Nakamura S. Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex. Neurosci. Lett. 111:1990;64-68.
58. Nakamura S. Effects of mianserin and fluoxetine on axonal regeneration of brain catecholamine neurons. NeuroReport. 2:1991;525-528.
59. Nakamura S. Axonal sprouting of noradrenergic locus coeruleus neurons following repeated stress and antidepressant treatment. Prog. Brain Res. 88:1991;587-598.
60. Nestler E.J., Terwilliger R.Z., Duman R.S. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53:1989;1644-1647.
61. Nibuya M., Rydelek-Fitzgerald L., Morinobu S., Russel D.S., Nestler E.J., Duman R.S. Induction of BDNF and trkB by electroconvulsive seizure (ECS): regional regulation and role of CREB. Soc. Neurosci. Abstr. 20:1994;1312.
62. B. O'Neill, B.E. Leonard, Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression, J. Affect. Disord. (1990) 265-272.
63. O'Neill B., O'Connor W.T., Leonard B.E. Depressed neutrophil phagocytosis in the rat following olfactory bulbectomy reversed by chronic desipramine treatment. Med. Sci. Res. 15:1987;276-278.
64. Ordway G.A., Gambarana C., Tejani-Butt S.M., Areso P., Hauptmann M., Frazer A. Preferential reduction of binding of 125I-Iodopindolol to Beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments. J. Pharmacol. Exp. Ther. 257:1991;681-690.
65. Ottersen O.P. Connections of the amygdala of the rat: IV. Corticoamygdaloid and intraamygdaloid connections as studied with axonal transport of horseradish peroxidase. J. Comp. Neurol. 205:1982;30-48.
66. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic press, Australia, 1986.
67. J.L. Price, F.T. Russchen, D.G. Amarel, The amygdaloid complex, in: A. Björklund, A. Hökfelt, L.W. Swanson (Eds.), Handbook of Chemical Neuroanatomy, Vol. 5, Integrated Systems of the CNS, Part 1, Elsevier, Amsterdam, 1987, pp. 279-381.
68. Scheff S.L., Bernado L., Cotman C. Progressive brain damage accelerates axon sprouting in the adult rat. Science. 197:1977;795-797.
69. Sharp F.R., Gonzalez M.F., Hisanaga K., Mobley W.C., Sagar S.M. Induction of the Fos gene product in rat forebrain following cortical lesions. Neurosci. Lett. 100:1989;117-122.
70. Sharp F.R., Sagar S.M. Alterations in gene expression as an index of neuronal injury: Heat shock and the immediate early gene response. Neurotoxicology. 15:1994;51-60.
71. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effects of Brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56:1997;131-137.
72. Song C., Kelly J.P., Leonard B.E. Alterations in immune and endocrine parameters following bulbectomy. Med. Sci. Res. 22:1994;593-595.
73. Song C., Leonard B.E. Effect of thymopeptides on the behaviour and some immunological responses in the olfactory bulbectomized rat. Med. Sci. Res. 20:1993;929-930.
74. Song C., Leonard B.E. Serotonin reuptake inhibitors reverse the impairments in behaviour, neurotransmitter and immune functions in the olfactory bulbectomized rat. Hum. Psychopharmacol. 9:1994;135-146.
75. R.C. Switzer, J. DeOlmos, L. Heimer, Olfactory system, The Rat Nervous System, Academic Press, Australia, 1985, pp. 1-36.
76. Ter Horst G.J., Knollema S., Knigge M.F., Krugers H.J., Van de Witte S.V., Postema F., Hom H.W. Silver staining of traumatized neurons: applications of a Gallyas procedure in experimental cerebral hypoxia/ischaemia research. Neurosci. Protocols. 50:1995;1-13.
77. Van Riezen H., Leonard B.E. Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats. Pharmacol. Ther. 74:1990;21-34.
78. Videbech P. MRI findings in patients with affective disorder: a meta-analysis, Acta Psych. Scand. 96:1997;157-168.
79. Winston S.M., Hayward M.D., Nestler E.J., Duman R.S. Chronic electroconvulsive seizure down-regulate expression of the immediate early genes Fos and Jun in rat cerebral cortex. J. Neurochem. 54:1990;1920-1925.
80. Wu J.C., Gillin J.C., Buchsbaum M.S., Hershey T., Johnson J.C., Bunney W.E. Effects of sleep deprivation on brain metabolism of depressed patients. Am. J. Psychiatry. 149:1992;538-543.
81. Zhou D., Grecksch G., Becker A., Frank C., Pilz C., Heuter C. Serotonergic hyperinnervation of the frontal cortex in an animal model of depression, the bulbectomized rat. J. Neurosci. Res. 54:1998;109-116.